Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Elevated Plasma Factor IXa Activity in Premenopausal Women on Hormonal Contraception

    Access Status
    Fulltext not available
    Authors
    Tanratana, P.
    Ellery, Paul
    Westmark, P.
    Mast, A.
    Sheehan, J.
    Date
    2018
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Tanratana, P. and Ellery, P. and Westmark, P. and Mast, A. and Sheehan, J. 2018. Elevated Plasma Factor IXa Activity in Premenopausal Women on Hormonal Contraception. Arteriosclerosis, Thrombosis, and Vascular Biology. 38 (1): pp. 266-274.
    Source Title
    Arteriosclerosis, Thrombosis, and Vascular Biology
    DOI
    10.1161/ATVBAHA.117.309919
    ISSN
    1079-5642
    School
    School of Pharmacy and Biomedical Sciences
    URI
    http://hdl.handle.net/20.500.11937/61201
    Collection
    • Curtin Research Publications
    Abstract

    Objective - Combined oral contraceptives induce a reversible hypercoagulable state with an enhanced risk of venous thromboembolism, but the underlying mechanism(s) remain unclear. Subjects on combined oral contraceptives also demonstrate a characteristic resistance to APC (activated protein C) in the thrombin generation assay. Here, we report the potential role of plasma factor IXa (FIXa) as a mechanism for hormone-induced systemic hypercoagulability. Approach and Results - A novel assay was used to determine FIXa activity in plasma samples from volunteer blood donors. Plasma from 36 premenopausal females on hormonal contraception and 35 not on hormonal contraception, 35 postmenopausal females, and 10 males were analyzed for FIXa activity, total PS (protein S), total tissue factor pathway inhibitor (TFPI), and TFPI-a antigen. Premenopausal females on hormonal contraception demonstrated significantly increased FIXa activity and decreased TFPI-a compared with the other groups. Remarkably, FIXa values were not normally distributed in the hormonal contraception group, but skewed toward the high end. Plasma FIXa activity inversely correlated with both TFPI-a and total PS antigen. Ex vivo determination of TF-dependent FIX activation in FV-deficient plasma demonstrated that inhibitory anti-TFPI antibodies enhanced FIXa generation by 2- to 3-fold, whereas addition of 75 nmol/L PS reduced FIXa generation by ˜2-fold. Further, increasing FIXa concentration enhanced APC resistance during TF-triggered plasma thrombin generation. Conclusions - Elevation of plasma FIXa activity in association with reductions in TFPI-a and PS is a potential mechanism for systemic hypercoagulability and resistance to APC in premenopausal females on hormonal contraception.

    Related items

    Showing items related by title, author, creator and subject.

    • Reduced prothrombinase inhibition by tissue factor pathway inhibitor contributes to the factor V Leiden hypercoagulable state
      Wood, J.; Kreuziger, L.; Ellery, Paul; Maroney, S.; Mast, A. (2017)
      Activated factor V (FVa) and factor X (FXa) form prothrombinase, which converts prothrombin to thrombin. The a isoform of tissue factor (TF) pathway inhibitor (TFPI) dampens early procoagulant events, partly by interacting ...
    • Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-a but not for cell surface-associated tissue factor pathway inhibitor
      Wood, J.; Ellery, Paul; Maroney, S.; Mast, A. (2014)
      OBJECTIVE - Tissue factor pathway inhibitor (TFPI) is produced in 2 isoforms: TFPIa, a soluble protein in plasma, platelets, and endothelial cells, and TFPIß, a glycosylphosphatidylinositol-anchored protein on endothelium. ...
    • Comparison of the inhibitory activities of human tissue factor pathway inhibitor (TFPI)a and TFPIß
      Maroney, S.; Ellery, Paul; Wood, J.; Ferrel, J.; Martinez, N.; Mast, A. (2013)
      Background: Tissue factor pathway inhibitor (TFPI) is an alternatively spliced protein with two isoforms, TFPIa and TFPIß, which differ in their C-terminal structure and cellular localization. Detailed characterization ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.